Back to Dividend Stocks
AZN.L

AstraZeneca PLC

EURO STOXX 600
AZN.L|Healthcare|Drug Manufacturers - General|£138.48|P/E 28.5|MCap 215.5B|LSE

Last update: Mar 25, 2026 at 04:53

About AstraZeneca PLC

AstraZeneca PLC is a multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It focuses on researching, developing, manufacturing, and commercializing innovative medicines and vaccines across key therapeutic areas including oncology, biopharmaceuticals, cardiovascular, renal, metabolism, respiratory, immunology, rare diseases, and infection. The company maintains major research and development centers in Cambridge, UK; Gaithersburg, Maryland, US; Gothenburg, Sweden; and Warsaw, Poland, supporting a pipeline that addresses cancer, cardiovascular diseases, kidney diseases, influenza, and other conditions. AstraZeneca PLC delivers products for primary care, specialty care, and global health initiatives, with operations spanning innovative medicines and biologics. Its portfolio emphasizes treatments for respiratory inflammation, autoimmune disorders, gastrointestinal issues, neuroscience, and vaccines, contributing to advancements in non-communicable diseases and access programs in various regions worldwide. Founded in 1999, AstraZeneca PLC plays a significant role in the global biopharmaceutical market through its comprehensive therapeutic focus and strategic R&D investments.

Dividend Overview

Dividend Yield

1.70%

Annual Dividend

£2.36

Frequency

Semi-Annual

Payout Ratio

47.91%

FCF Payout Ratio

57.34%

Stock Price

£138.48

52-Week Range

£95.73 £157.32

Dividend Health Score

77/ 100Safe

AZN.L's dividend appears safe and well-supported. Strengths include a 47.9% earnings payout ratio & 57.3% fcf payout ratio. Areas of concern: 0.9x current ratio & Volatile profit margin stability.

Based on 15 of 15 metrics

Payout & Coverage

Safe
Earnings Payout Ratio
47.9%Very Safe
FCF Payout Ratio
57.3%Safe
CFO Payout Ratio
42.4%Safe
Interest Coverage
8.7xSafe

Balance Sheet

Caution
Net Debt / Total Assets
20.5%Safe
Current Ratio
0.9xWarning
Debt-to-Equity
61.0Safe

Profitability

Safe
Return on Equity
22.8%Very Safe
Operating Margin
21.6%Safe
Gross Margin
79.9%Very Safe
Profit Margin Stability
VolatileWarning

Dividend Track Record

Very Safe
Dividend Streak
11+ yrsVery Safe
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
2.5%Caution
Earnings Stability
GrowingVery Safe

Dividend History (2016–2025)

AZN.L annual dividend per share and yield history

Earnings & Profitability

AZN.L earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

February 19, 2026

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

3.34%

5-Year Dividend CAGR

2.53%

10-Year Dividend CAGR

6.95%

3-Year Total Growth

10.37%

5-Year Total Growth

13.29%

10-Year Total Growth

95.76%

Income Calculator

AZN.L Dividend Calculator

Total Investment

£13,848.00

Annual Income

£236.20

Quarterly Income

£59.05

Monthly Income

£19.68

Similar Dividend Stocks

StockYield5Y CAGRPrice
AZN.L
AZN.L
1.70%2.53%£138.48
CTEC.L
CTEC.L
2.29%2.74%£2.23
GSK.L
GSK.L
3.38%-7.66%£19.70
HIK.L
HIK.L
4.99%12.07%£12.29
HLN.L
HLN.L
1.81%N/A£3.60
SN.L
SN.L
2.40%-0.74%£12.03

Frequently Asked Questions

What is AZN.L's current dividend yield?
AstraZeneca PLC (AZN.L) currently has a dividend yield of 1.70%, based on a stock price of £138.48 and an annual dividend of £2.36.
When is AZN.L's next dividend payment date?
AZN.L's next ex-dividend date is 2026-02-19 and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does AZN.L pay in dividends per year?
AstraZeneca PLC paid £2.45 per share in annual dividends in 2025. The dividends are paid semi-annual.
Has AZN.L been increasing its dividend?
AstraZeneca PLC has grown its dividend at a 5-year CAGR of 2.53% and a 10-year CAGR of 6.95%.
Is AZN.L's dividend safe?
AstraZeneca PLC has a payout ratio of 47.91%. Its free cash flow payout ratio is 57.34%. A payout ratio below 60% is generally considered sustainable.
How is AZN.L's Dividend Health Score calculated?
The Dividend Health Score evaluates AstraZeneca PLC's dividend sustainability across four categories: Payout & Coverage (40%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (20%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track AZN.L Dividends with OnlyDividends

What will AZN.L actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Health Score, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.